Dual-energy CT radiomics for predicting neoadjuvant chemotherapy response in locally advanced gastric cancer: A dual-vendor validation study
European Journal of Surgical Oncology · 2025
DOI: 10.1016/j.ejso.2025.110548 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Jing Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China; HNHC Key Laboratory…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Neoadjuvant Therapy, Tomography, X-Ray Computed, Radiomics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: To establish and validate a dual-energy CT (DECT) radiomics model for predicting neoadjuvant chemotherapy (NAC) response in locally advanced gastric cancer (LAGC) across two vendors. METHODS: This was a secondary analysis drawn from a prospective cohort using DECT data of patients undergoing NAC followed by gastrectomy. Patients were stratified as responders (TRG 0/1) or non-responders (TRG 2/3) based on tumor regression grade (TRG). Radiomics features were extracted from polychromatic images at arterial/venous/delayed phases for building CECT model; Radiomics features extracted from polychromatic images, monochromatic (40 keV, 100 keV) and iodine maps were used to construct DECT model. Predictive features were selected via the least absolute shrinkage and selection operator regression method in the training cohort and tested in the validation cohort. Performances of models were evaluated using areas under the receiver operating characteristic curves (AUCs). RESULTS: In total, 317 patients were recruited: 221 at training dataset (59.9 ± 9.7 years, 37 females, 184 males) and 96 at validation dataset (61.5 ± 8.0 years, 18 females, 78 males). No clinical factors were found to be related with TRG status. The DECT model outperformed CECT model in the training dataset (AUC: 0.806 vs. 0.729, p = 0.041) and showed non-significant superiority in the validation dataset (AUC: 0.752 vs. 0.679, p = 0.225). High-risk patients defined by DECT model had significantly worse overall survival (HR = 1.996, p = 0.012) and disease-free survival (HR = 1.873, p = 0.037) than low-risk counterparts. CONCLUSION: DECT radiomics demonstrates favorable performance in predicting NAC response and stratifying survival outcomes in LAGC, with cross-vendor generalizability supporting potential clinical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China; HNHC Key Laboratory of Oncology Medical Imaging Response Assessment, Henan Cancer Hospita…
- Infervision Medical Technology Co., Ltd., Beijing, 100025, China. Electronic address: yinhk1985@gmail.com.
- Department of Gastrointestinal oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China. Electronic address: lindaxsn1985@163.com.
- Department of Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China. Electronic address: wyft1022@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Lin, X., Yin, H., Bei, T., Yao, X., Chen, X., Xu, S., Wang, Y., & Qu, J. (2025). Dual-energy CT radiomics for predicting neoadjuvant chemotherapy response in locally advanced gastric cancer: A dual-vendor validation study. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110548
Vancouver
Li J, Lin X, Yin H, Bei T, Yao X, Chen X, et al. Dual-energy CT radiomics for predicting neoadjuvant chemotherapy response in locally advanced gastric cancer: A dual-vendor validation study. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110548
BibTeX
@article{Li2025,
author = {Li, Jing and Lin, Xiaoxiao and Yin, Hongkun and Bei, Tianxia and Yao, Xiaoqiang and Chen, Xuejun and Xu, Shuning and Wang, Yi and Qu, Jinrong},
title = {Dual-energy CT radiomics for predicting neoadjuvant chemotherapy response in locally advanced gastric cancer: A dual-vendor validation study},
journal = {European Journal of Surgical Oncology},
year = {2025},
doi = {10.1016/j.ejso.2025.110548}
}
EUVIMED